Cell Based Assay Market is Expected to Reach US$ 18.5 Bn by 2025

Analyst Speak:

The Global Cell Based Assay Market is expected to reach US$ 18.5 Bn by 2025 owing to growth in R&D for the development of newer techniques

The global cell based assay market is expected to reach US$ 18.5 Bn by 2025. The factors which are driving the growth of global cell based assay market are raising demand for biological drugs, upsurge in the frequency and incidence of chronic diseases such as cancer, technological advancements in the drug discovery process, escalating research and development, increasing awareness in the government about the toxicity screening in drugs, and upsurge in government funding for the products. Moreover, growth in the adoption of cell-based consumables by various organizations might propel the cell-based assay market over the coming years. The global cell based assay market is also driven by the numerous advantages this technique provides such as to determine the different parameters such as biochemical or cellular functions of a living cell, to measure motility, cell proliferation, toxicity, enzyme activity, and morphology in the diagnostics and drug discovery. They are also used in the research of new drugs by using functional cells as diagnostic tools. Cell based assay is approved in several therapeutic areas such as cancer, stem cells, immunology, and others. Still, deficiency of skilled professionals for conducting the cell based assays, the high cost of the instruments, and rigorous regulatory guidelines might obstruct the growth of cell based assay market.

Global cell based assay market is segmented on the basis of product type, application, end user, and region.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=16684

ADME Studies Dominate the Global Cell Based Assay Market

Based on the application, global cell based assay market is segmented into ADME studies, basic research, predictive toxicology, drug discovery, and other. ADME studies dominate the global cell based assay market because through this a drugs metabolism inside the body can be known and it also helps in the design and development of new drug products. An ADME study tells about the drugs absorption, distribution, metabolism, and excretion.

North America Leads the Global Cell Based Assay Market

PBI’s global cell based assay market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global cell based assay market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in prevalence of chronic diseases such as cancer for instance in 2016, there were an estimated 15.5 million cancer survivors in the United States (according to National Cancer Institute). Additionally, technological advancements, escalating funding from government, improved research and development facilities fuel the growth of cell based assay market in North American region. Europe cell based assay market estimated for a substantial share in global cell based assay market due to its increasing disposable income especially in country like UK, increasing research and development in the field of drug discovery, and growing occurrences of chronic diseases. According to World Health Organization Europe accounts for one quarter of the total global cancer cases. Asia Pacific cell based assay market is expected to grow significantly due to their developing economies, development of new techniques, increase in the prevalence of diseases, continuously growing population, development of healthcare infrastructure, and technological advancements.

Development of newer assay techniques and strategic alliances are the key strategies adopted by market players

Global cell based assay market further reveals that the key player’s increasingly adopting strategies such as development of newer techniques, mergers and collaborations to improve market revenue share and gaining significant geographic presence across the region.

  • For instance, in January 2019, Beckman Coulter launced “ClearLLab 10C system for clinical flow cytometry lab.
  • Furthermore, in May 2019, Thermo Fisher Scientific announced the launch of “Immune Cell Types Family of Assays”

Key player’s profiles in the report are PerkinElmer Inc. (USA), GE Healthcare (UK), ProQinase GmbH (Germany), Danaher Corporation (USA), Essen BioScience Inc. (USA), Lonza Group (USA), Thermo Fisher Scientific Inc. (USA), Abenex Capital SA (France), Axiogenesis AG (Germany), and Beckman Coulter (USA), Metrion Biosciences Ltd. (UK).

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-cell-based-assay-market/

Precision Business Insights (PBI) in its report titled “Global Cell Based Assay Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation

By Product Type

  • Consumables
  • Assay Kits
  • Reagents
  • Cell growth assay
  • Reporter gene assay
  • Immortalized cell lines
  • Stem cell lines
  • Primary cell lines
  • Others

By Application

  • ADME studies
  • Basic research
  • Predictive toxicology
  • Drug discovery
  • Other

By End User

  • Diagnostic Centers
  • Hospitals
  • Biopharmaceutical companies
  • Contract research organizations

Geography

North America

  • USA
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ shreya@precisionbusinessinsights.com
Call @ +1-866-598-1553
Precision Business Insights